Information Provided By:
Fly News Breaks for December 13, 2018
HIIQ
Dec 13, 2018 | 15:02 EDT
Lake Street analyst Mark Argento reiterated a Buy rating and $75 price target on Health Insurance Innovations, noting the company was found not to have committed any wrongdoing in the multi-state investigation, which began back in 2016. Argento said Health Insurance Innovations can now move forward with multiple partner and carrier opportunities, which have been on hold pending the outcome of this investigation. Additionally, announced an increased buyback to $50M-$100M, which the analyst views as a "significant positive."
News For HIIQ From the Last 2 Days
There are no results for your query HIIQ